Prozomix Limited is a privately owned UK biotechnology company that develops, produces and supplies a large, diverse and rapidly expanding range of highly purified recombinant enzymes and proteins of known sequence with associated biochemical reagents, kits and services for the pure and applied researcher.
Our drive for product growth respects the Academiome (i.e. the global academic resource) as evidenced by our Commercial Academic Partner (CAP) Programme, that enables rapid and efficient commercialisation of enzyme / protein encoding plasmids, in exchange for a generous royalty of 17.5 %. A further CAP Referrer Programme rewards those who refer research scientists to the Prozomix CAP Programme, with a generous royalty of 2.5 %.
Our strength is not only our expanding recombinant catalogue, but the 365 days-a-year rapid technical support that fully backs it up. Such comprehensive technical support, as appreciated by today’s researcher, is enabled by our very active in-house Research and Development Team, that in addition to supporting existing products, is scheduled to add on average 5 new products to our range per week during 2009.
The Prozomix e-commerce web site (www.prozomix.com) seamlessly marries post-genomic technologies with enzyme / protein commercialisation to offer today’s research scientist the most efficient and transparent purchasing experience available. For example, not only is our recombinant enzyme and protein range BLAST searchable, but primary sequences are freely available and easily accessible for every product. Another novel on-line feature is our interactive product development pipeline that is publically visible in real-time, and offers the ability to “fast track” the manufacture of a desired recombinant enzyme(s) or protein(s) with just a click of the mouse.
